论文部分内容阅读
在美国进行的一项开放式多中心临床研究通过非劣性临床试验设计方式,以高加索白色人种作为参照组,对20 mg他达拉非治疗美国黑色人种和拉美裔勃起功能障碍(ED)患者的疗效进行评估。该研究的次级目标是了解20 mg他达拉非在不同ED患者人群中的疗效和安全性。共有1 911例ED患者入选
In an open multicenter clinical study in the United States, 20 mg tadalafil-treated African Americans and Hispanic erectile dysfunction (ED) were treated with a non-inferiority clinical trial design using Caucasians as a reference group, The patient’s efficacy was assessed. The secondary goal of this study was to understand the efficacy and safety of 20 mg tadalafil in different ED patient populations. A total of 1 911 cases of ED patients were enrolled